Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Andreas Huettmann"'
Autor:
Christian Hoffmann, Christopher Mohr, Patricia Johansson, Anja Eckstein, Andreas Huettmann, Julia von Tresckow, Sophia Göricke, Cornelius Deuschl, Christoph Poettgen, Thomas Gauler, Nika Guberina, Sourour Moliavi, Nikolaos Bechrakis, Martin Stuschke, Maja Guberina
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract We systematically analyzed the kinetics of tumor regression, the impact of residual lesions on disease control and the applicability of the Lugano classification in follow-up MRI of orbital non-Hodgkin lymphomas that were irradiated with pho
Externí odkaz:
https://doaj.org/article/005e9031ded644e798179c4d18ea915e
Autor:
Maurizio Martelli, Luca Ceriani, Emanuele Zucca, Irina Kryachok, Giovannino Ciccone, Umberto Ricardi, Barbara Botto, Monica Balzarotti, Alessandra Tucci, Sara Veronica Usai, Elsa Pennese, Luca Arcaini, Anna Dabrowska-Iwanicka, Andrés José María Ferreri, Francesco Marli, Weili Zhao, David Hodgson, Codruta Ionescu, Luigi Rigacci, Claudia Cellini, Caterina Stelitano, Francesco Zaja, Attilio Guarini, Michele Spina, Alexander Fossa, Kate Cwynarski, N. George Mikhaeel, Mats Jerkeman, Andrea Janíková, Andreas Huettmann, Maria Gomes Da Silva, Don Stevens, Luigi Petrucci, Sally Barrington, Bogdan Malkowski, Ur Metser, Annibale Versari, Oreste Bagni, Stephane Chauvie, Kelly Cozens, Sonia Perticone, Nicoletta Ielmini, Franco Cavalli, Mary Gosodarowicz, Peter W. Johnson, Andrew Davies
Publikováno v:
HemaSphere, Vol 7, p e2454568 (2023)
Externí odkaz:
https://doaj.org/article/2d4c1e23f7cf4983acf9cd9c0248e729
Autor:
Christian Hoffmann, Toke Ringbaek, Anja Eckstein, Wolfgang Deya, Alina Santiago, Martin Heintz, Wolfgang Lübcke, Frank Indenkämpen, Wolfgang Sauerwein, Andrea Flühs, Claudia Le Guin, Andreas Huettmann, Julia von Tresckow, Sophia Göricke, Cornelius Deuschl, Sourour Moliavi, Christoph Poettgen, Thomas Gauler, Nika Guberina, Patricia Johansson, Nikolaos Bechrakis, Martin Stuschke, Maja Guberina
Publikováno v:
Cancers, Vol 15, Iss 22, p 5433 (2023)
Irradiation with electrons is the primary treatment regime for localized conjunctival low-grade lymphomas. However, radiation-induced cataracts are a major cause of treatment-related morbidity. This study investigates whether lens-sparing electron ir
Externí odkaz:
https://doaj.org/article/1f72176476844e04ab50c39601f48da3
Autor:
Christian Hoffmann, Philipp Rating, Nikolaos Bechrakis, Anja Eckstein, Ekaterina Sokolenko, Leyla Jabbarli, Henrike Westekemper, Christopher Mohr, Claus Schmeling, Andreas Huettmann, Julia von Tresckow, Sophia Göricke, Cornelius Deuschl, Patricia Johansson, Christoph Poettgen, Thomas Gauler, Nika Guberina, Sourour Moliavi, Martin Stuschke, Maja Guberina
Publikováno v:
Hematological Oncology. 40:922-929
We assessed the long-term outcomes and treatment-related adverse effects of patients with Stage I, “orbital-type” lymphomas that were uniformly treated with photons. All consecutive patients diagnosed with low-grade, Ann Arbor Stage IEA orbital l
Autor:
Anne Sophie Jacob, Helen Kaul, Michael Fuchs, Sarah Gillessen, Stefanie Kreissl, Annette Pluetschow, Jesko Momotow, Valdete Schaub, Andreas Huettmann, Mathias Haenel, Andreas Zimmermann, Judith Dierlamm, Julia Meissner, Stephan Mathas, Sonja Martin, Andreas Engert, Michael Hallek, Peter Borchmann, Clara Lehmann
Publikováno v:
Infection. 50:925-932
Purpose Evidence on the effect of self-protection via social distancing and wearing face-masks on infections during chemotherapy is currently not available. We asked if the occurrence of acute infections during chemotherapy for advanced-stage Hodgkin
Autor:
Christiane Pott, Christian Koenecke, Fabian Acker, Corinna Leng, Léandra Caillé, Andrea Kerkhoff, Dimitrios Mougiakakos, Georg Hess, Sascha Dietrich, Jan-Moritz Middeke, Udo Holtick, Thomas Geer, Jens M. Chemnitz, Andreas Huettmann, Eva Kaebisch, Ruediger Liersch, Rainer Claus, Stephan Fuhrmann, Donnacha Fitzgerald, Uta Brunnberg, Lars Bullinger, Nora Liebers, Arne Trummer, Ralf Ulrich Trappe, Niklas Gebauer, Georg Lenz, Manfred Welslau, Gerald Wulf, Carsten Mueller-Tidow, Stefan Fuxius, Johannes Duell, Peter Dreger, Stephanie Mayer, Bertram Glass, Daniel Noerenberg, Thomas Weber, Christian Spoer, Roald Pfannes, Ulrich Keller
Publikováno v:
Blood Adv
The antibody-drug conjugate polatuzumab vedotin (pola) has recently been approved in combination with bendamustine and rituximab (pola-BR) for patients with refractory or relapsed (r/r) large B-cell lymphoma (LBCL). To investigate the efficacy of pol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc9ee0869bc913161af8eed2ce06a7ab
http://edoc.mdc-berlin.de/20400/7/20400suppl.pdf
http://edoc.mdc-berlin.de/20400/7/20400suppl.pdf
Autor:
Maximilian Diehn, David M. Kurtz, Alexander F.M. Craig, Lyron Co Ting Keh, Michael C. Jin, Mark Roschewski, Gianluca Gaidano, Andre Schultz, Chih Long Liu, Andreas Huettmann, Davide Rossi, Florian Scherer, Wyndham H. Wilson, Joanne Soo, Jacob J. Chabon, Stefan Alig, Rene-Olivier Casasnovas, Jason R. Westin, Ash A. Alizadeh, Ulrich Duehrsen
7565 Background: Detection of circulating tumor DNA (ctDNA) has prognostic value in diverse tumors, including DLBCL. Despite uses for assessing molecular response to therapy, current methods using immunoglobulin or hybrid-capture sequencing have subo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd2cba39b5dcdfbd665162ed91a55542
Autor:
Steven M. Horwitz, Árpád Illés, Pier Luigi Zinzani, David Belada, Tatyana Feldman, Andreas Huettmann, Owen A. O'Connor, Hervé Tilly, Timothy M Illidge, Won Seog Kim, Nancy L. Bartlett, Eric D. Jacobsen, M. Onsum, Swaminathan Padmanabhan Iyer, Ranjana H. Advani, Harry H. Miao, Thomas Manley, Shangbang Rao, William L. Trepicchio
Publikováno v:
Hematological Oncology. 37:281-283
7538 Background: Brentuximab vedotin (BV) is an antibody-drug conjugate that targets CD30. The ECHELON-2 (E-2) study demonstrated significantly longer progression-free and overall survival with BV plus cyclophosphamide, doxorubicin, and prednisone (A
Autor:
Andreas Huettmann, Lorenz Truemper, Justin Hasenkamp, Norbert Schmitz, Hans Salwender, Martin Dreyling, Michael G. Kiehl, Bertram Glass, Maike Nickelsen, Sebastian Pfeiffer, Anke Goerlitz
Publikováno v:
Blood. 124:1754-1754
Background: Primary treatment results of aggressive B-NHL improved substantially after introduction of chemoimmunotherapy. However, current salvage treatment of primary progressive and relapsed disease is often disappointing with remission rates of <
Autor:
Ingo G.H. Schmidt-Wolf, Eike C. Buss, Anke Morgner, Monika Brueggemann, Andreas Huettmann, Stefan Schwartz, Nicola Goekbuget, Matthias Stelljes, Andreas Viardot, Norbert Frickhofen, Thomas Burmeister, Dieter Hoelzer, Knut Wendelin, Hubert Serve, Michael Starck, Bernd M. Spriewald, Albrecht Reichle, Joachim Beck
Publikováno v:
Blood. 120:1493-1493
Abstract 1493 Few older ALL pts are entered into prospective trials and data on characteristics and outcome are scarce. The GMALL started a prospective trial in older ALL (>55 yrs) in 2003. In Ph-neg ALL a prephase (Dexa, Cyclo, MTX i.th.) was follow